Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02285348 : Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T
PhaseN/A
AgesMin: 2 Years Max: 40 Years
Eligibility
Inclusion Criteria:

- Aim group: clinically and/or genetically diagnosed Ataxia telangiectasia; Control
group: neurologic non-inflammatory disease with an indication for diagnostic or
therapeutic lumbar puncture

- age between 2 and 40 years

- written informed consent

Exclusion Criteria:

- fever or clinical signs of an infection

- leucocyte count >12´000/µl and C reactive protein (CrP) >2mg/dl

- chronic diseases with need of immunomodulatory therapies (bronchial asthma,
rheumatoid arthritis)

- medication with statins

- other diseases with influence in the immunosystem (i.e. diabetes mellitus, malignoma,
renal failure requiring dialysis)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02285348      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740